Global Cancer Nanomedicine Market Insights, Forecast to 2029

Global Cancer Nanomedicine Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Cancer Nanomedicine Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Nanomedicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inorganic Nanoparticles
1.2.3 Protein Nanoparticles
1.2.4 Polymer Nanoparticles
1.2.5 Lipid Organic Nanoparticles
1.3 Market by Application
1.3.1 Global Cancer Nanomedicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Breast Cancer
1.3.3 Pancreatic Cancer
1.3.4 Brain Cancer
1.3.5 Lung Cancer
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cancer Nanomedicine Sales Estimates and Forecasts 2018-2029
2.2 Global Cancer Nanomedicine Revenue by Region
2.2.1 Global Cancer Nanomedicine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Cancer Nanomedicine Revenue by Region (2018-2023)
2.2.3 Global Cancer Nanomedicine Revenue by Region (2024-2029)
2.2.4 Global Cancer Nanomedicine Revenue Market Share by Region (2018-2029)
2.3 Global Cancer Nanomedicine Sales Estimates and Forecasts 2018-2029
2.4 Global Cancer Nanomedicine Sales by Region
2.4.1 Global Cancer Nanomedicine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Cancer Nanomedicine Sales by Region (2018-2023)
2.4.3 Global Cancer Nanomedicine Sales by Region (2024-2029)
2.4.4 Global Cancer Nanomedicine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Cancer Nanomedicine Sales by Manufacturers
3.1.1 Global Cancer Nanomedicine Sales by Manufacturers (2018-2023)
3.1.2 Global Cancer Nanomedicine Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cancer Nanomedicine in 2022
3.2 Global Cancer Nanomedicine Revenue by Manufacturers
3.2.1 Global Cancer Nanomedicine Revenue by Manufacturers (2018-2023)
3.2.2 Global Cancer Nanomedicine Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Cancer Nanomedicine Revenue in 2022
3.3 Global Key Players of Cancer Nanomedicine, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Cancer Nanomedicine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Cancer Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Cancer Nanomedicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Cancer Nanomedicine, Product Offered and Application
3.8 Global Key Manufacturers of Cancer Nanomedicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cancer Nanomedicine Sales by Type
4.1.1 Global Cancer Nanomedicine Historical Sales by Type (2018-2023)
4.1.2 Global Cancer Nanomedicine Forecasted Sales by Type (2024-2029)
4.1.3 Global Cancer Nanomedicine Sales Market Share by Type (2018-2029)
4.2 Global Cancer Nanomedicine Revenue by Type
4.2.1 Global Cancer Nanomedicine Historical Revenue by Type (2018-2023)
4.2.2 Global Cancer Nanomedicine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Cancer Nanomedicine Revenue Market Share by Type (2018-2029)
4.3 Global Cancer Nanomedicine Price by Type
4.3.1 Global Cancer Nanomedicine Price by Type (2018-2023)
4.3.2 Global Cancer Nanomedicine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Cancer Nanomedicine Sales by Application
5.1.1 Global Cancer Nanomedicine Historical Sales by Application (2018-2023)
5.1.2 Global Cancer Nanomedicine Forecasted Sales by Application (2024-2029)
5.1.3 Global Cancer Nanomedicine Sales Market Share by Application (2018-2029)
5.2 Global Cancer Nanomedicine Revenue by Application
5.2.1 Global Cancer Nanomedicine Historical Revenue by Application (2018-2023)
5.2.2 Global Cancer Nanomedicine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Cancer Nanomedicine Revenue Market Share by Application (2018-2029)
5.3 Global Cancer Nanomedicine Price by Application
5.3.1 Global Cancer Nanomedicine Price by Application (2018-2023)
5.3.2 Global Cancer Nanomedicine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Cancer Nanomedicine Market Size by Type
6.1.1 US & Canada Cancer Nanomedicine Sales by Type (2018-2029)
6.1.2 US & Canada Cancer Nanomedicine Revenue by Type (2018-2029)
6.2 US & Canada Cancer Nanomedicine Market Size by Application
6.2.1 US & Canada Cancer Nanomedicine Sales by Application (2018-2029)
6.2.2 US & Canada Cancer Nanomedicine Revenue by Application (2018-2029)
6.3 US & Canada Cancer Nanomedicine Market Size by Country
6.3.1 US & Canada Cancer Nanomedicine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Cancer Nanomedicine Sales by Country (2018-2029)
6.3.3 US & Canada Cancer Nanomedicine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Cancer Nanomedicine Market Size by Type
7.1.1 Europe Cancer Nanomedicine Sales by Type (2018-2029)
7.1.2 Europe Cancer Nanomedicine Revenue by Type (2018-2029)
7.2 Europe Cancer Nanomedicine Market Size by Application
7.2.1 Europe Cancer Nanomedicine Sales by Application (2018-2029)
7.2.2 Europe Cancer Nanomedicine Revenue by Application (2018-2029)
7.3 Europe Cancer Nanomedicine Market Size by Country
7.3.1 Europe Cancer Nanomedicine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Cancer Nanomedicine Sales by Country (2018-2029)
7.3.3 Europe Cancer Nanomedicine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Cancer Nanomedicine Market Size
8.1.1 China Cancer Nanomedicine Sales (2018-2029)
8.1.2 China Cancer Nanomedicine Revenue (2018-2029)
8.2 China Cancer Nanomedicine Market Size by Application
8.2.1 China Cancer Nanomedicine Sales by Application (2018-2029)
8.2.2 China Cancer Nanomedicine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cancer Nanomedicine Market Size by Type
9.1.1 Asia Cancer Nanomedicine Sales by Type (2018-2029)
9.1.2 Asia Cancer Nanomedicine Revenue by Type (2018-2029)
9.2 Asia Cancer Nanomedicine Market Size by Application
9.2.1 Asia Cancer Nanomedicine Sales by Application (2018-2029)
9.2.2 Asia Cancer Nanomedicine Revenue by Application (2018-2029)
9.3 Asia Cancer Nanomedicine Sales by Region
9.3.1 Asia Cancer Nanomedicine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Cancer Nanomedicine Revenue by Region (2018-2029)
9.3.3 Asia Cancer Nanomedicine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Cancer Nanomedicine Market Size by Type
10.1.1 Middle East, Africa and Latin America Cancer Nanomedicine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Cancer Nanomedicine Market Size by Application
10.2.1 Middle East, Africa and Latin America Cancer Nanomedicine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Cancer Nanomedicine Sales by Country
10.3.1 Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Cancer Nanomedicine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Alnylam Pharmaceuticals, Inc
11.1.1 Alnylam Pharmaceuticals, Inc Company Information
11.1.2 Alnylam Pharmaceuticals, Inc Overview
11.1.3 Alnylam Pharmaceuticals, Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Alnylam Pharmaceuticals, Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Alnylam Pharmaceuticals, Inc Recent Developments
11.2 Amgen Inc
11.2.1 Amgen Inc Company Information
11.2.2 Amgen Inc Overview
11.2.3 Amgen Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Amgen Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amgen Inc Recent Developments
11.3 Arrowhead Pharmaceuticals, Inc
11.3.1 Arrowhead Pharmaceuticals, Inc Company Information
11.3.2 Arrowhead Pharmaceuticals, Inc Overview
11.3.3 Arrowhead Pharmaceuticals, Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Arrowhead Pharmaceuticals, Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Arrowhead Pharmaceuticals, Inc Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 AstraZeneca Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Cadila Pharmaceuticals
11.5.1 Cadila Pharmaceuticals Company Information
11.5.2 Cadila Pharmaceuticals Overview
11.5.3 Cadila Pharmaceuticals Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Cadila Pharmaceuticals Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Cadila Pharmaceuticals Recent Developments
11.6 CELGENE CORPORATION
11.6.1 CELGENE CORPORATION Company Information
11.6.2 CELGENE CORPORATION Overview
11.6.3 CELGENE CORPORATION Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 CELGENE CORPORATION Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 CELGENE CORPORATION Recent Developments
11.7 Celsion Corporation
11.7.1 Celsion Corporation Company Information
11.7.2 Celsion Corporation Overview
11.7.3 Celsion Corporation Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Celsion Corporation Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Celsion Corporation Recent Developments
11.8 Genzyme
11.8.1 Genzyme Company Information
11.8.2 Genzyme Overview
11.8.3 Genzyme Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Genzyme Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genzyme Recent Developments
11.9 Merck & Co., Inc
11.9.1 Merck & Co., Inc Company Information
11.9.2 Merck & Co., Inc Overview
11.9.3 Merck & Co., Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Merck & Co., Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck & Co., Inc Recent Developments
11.10 Nippon Kayaku Co.,Ltd
11.10.1 Nippon Kayaku Co.,Ltd Company Information
11.10.2 Nippon Kayaku Co.,Ltd Overview
11.10.3 Nippon Kayaku Co.,Ltd Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Nippon Kayaku Co.,Ltd Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Nippon Kayaku Co.,Ltd Recent Developments
11.11 Nanobiotix
11.11.1 Nanobiotix Company Information
11.11.2 Nanobiotix Overview
11.11.3 Nanobiotix Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Nanobiotix Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Nanobiotix Recent Developments
11.12 Pfizer Inc
11.12.1 Pfizer Inc Company Information
11.12.2 Pfizer Inc Overview
11.12.3 Pfizer Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Pfizer Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Pfizer Inc Recent Developments
11.13 F. Hoffmann-La Roche Ltd
11.13.1 F. Hoffmann-La Roche Ltd Company Information
11.13.2 F. Hoffmann-La Roche Ltd Overview
11.13.3 F. Hoffmann-La Roche Ltd Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 F. Hoffmann-La Roche Ltd Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 F. Hoffmann-La Roche Ltd Recent Developments
11.14 Takeda Pharmaceutical Company Limited
11.14.1 Takeda Pharmaceutical Company Limited Company Information
11.14.2 Takeda Pharmaceutical Company Limited Overview
11.14.3 Takeda Pharmaceutical Company Limited Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 Takeda Pharmaceutical Company Limited Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Takeda Pharmaceutical Company Limited Recent Developments
11.15 General Electric
11.15.1 General Electric Company Information
11.15.2 General Electric Overview
11.15.3 General Electric Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 General Electric Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 General Electric Recent Developments
11.16 Johnson & Johnson Services, Inc
11.16.1 Johnson & Johnson Services, Inc Company Information
11.16.2 Johnson & Johnson Services, Inc Overview
11.16.3 Johnson & Johnson Services, Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Johnson & Johnson Services, Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Johnson & Johnson Services, Inc Recent Developments
11.17 Teva Pharmaceutical Industries Ltd
11.17.1 Teva Pharmaceutical Industries Ltd Company Information
11.17.2 Teva Pharmaceutical Industries Ltd Overview
11.17.3 Teva Pharmaceutical Industries Ltd Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Teva Pharmaceutical Industries Ltd Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.18 Gilead Sciences, Inc
11.18.1 Gilead Sciences, Inc Company Information
11.18.2 Gilead Sciences, Inc Overview
11.18.3 Gilead Sciences, Inc Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Gilead Sciences, Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Gilead Sciences, Inc Recent Developments
11.19 Novartis AG
11.19.1 Novartis AG Company Information
11.19.2 Novartis AG Overview
11.19.3 Novartis AG Cancer Nanomedicine Sales, Price, Revenue and Gross Margin (2018-2023)
11.19.4 Novartis AG Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Novartis AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cancer Nanomedicine Industry Chain Analysis
12.2 Cancer Nanomedicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cancer Nanomedicine Production Mode & Process
12.4 Cancer Nanomedicine Sales and Marketing
12.4.1 Cancer Nanomedicine Sales Channels
12.4.2 Cancer Nanomedicine Distributors
12.5 Cancer Nanomedicine Customers
13 Market Dynamics
13.1 Cancer Nanomedicine Industry Trends
13.2 Cancer Nanomedicine Market Drivers
13.3 Cancer Nanomedicine Market Challenges
13.4 Cancer Nanomedicine Market Restraints
14 Key Findings in The Global Cancer Nanomedicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Cancer Nanomedicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inorganic Nanoparticles
Table 3. Major Manufacturers of Protein Nanoparticles
Table 4. Major Manufacturers of Polymer Nanoparticles
Table 5. Major Manufacturers of Lipid Organic Nanoparticles
Table 6. Global Cancer Nanomedicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Cancer Nanomedicine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Cancer Nanomedicine Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Cancer Nanomedicine Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Cancer Nanomedicine Revenue Market Share by Region (2018-2023)
Table 11. Global Cancer Nanomedicine Revenue Market Share by Region (2024-2029)
Table 12. Global Cancer Nanomedicine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Cancer Nanomedicine Sales by Region (2018-2023) & (K Units)
Table 14. Global Cancer Nanomedicine Sales by Region (2024-2029) & (K Units)
Table 15. Global Cancer Nanomedicine Sales Market Share by Region (2018-2023)
Table 16. Global Cancer Nanomedicine Sales Market Share by Region (2024-2029)
Table 17. Global Cancer Nanomedicine Sales by Manufacturers (2018-2023) & (K Units)
Table 18. Global Cancer Nanomedicine Sales Share by Manufacturers (2018-2023)
Table 19. Global Cancer Nanomedicine Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Cancer Nanomedicine Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Cancer Nanomedicine, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Cancer Nanomedicine Price by Manufacturers 2018-2023 (US$/Unit)
Table 23. Global Cancer Nanomedicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Cancer Nanomedicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Nanomedicine as of 2022)
Table 25. Global Key Manufacturers of Cancer Nanomedicine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Cancer Nanomedicine, Product Offered and Application
Table 27. Global Key Manufacturers of Cancer Nanomedicine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Cancer Nanomedicine Sales by Type (2018-2023) & (K Units)
Table 30. Global Cancer Nanomedicine Sales by Type (2024-2029) & (K Units)
Table 31. Global Cancer Nanomedicine Sales Share by Type (2018-2023)
Table 32. Global Cancer Nanomedicine Sales Share by Type (2024-2029)
Table 33. Global Cancer Nanomedicine Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Cancer Nanomedicine Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Cancer Nanomedicine Revenue Share by Type (2018-2023)
Table 36. Global Cancer Nanomedicine Revenue Share by Type (2024-2029)
Table 37. Cancer Nanomedicine Price by Type (2018-2023) & (US$/Unit)
Table 38. Global Cancer Nanomedicine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Cancer Nanomedicine Sales by Application (2018-2023) & (K Units)
Table 40. Global Cancer Nanomedicine Sales by Application (2024-2029) & (K Units)
Table 41. Global Cancer Nanomedicine Sales Share by Application (2018-2023)
Table 42. Global Cancer Nanomedicine Sales Share by Application (2024-2029)
Table 43. Global Cancer Nanomedicine Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Cancer Nanomedicine Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Cancer Nanomedicine Revenue Share by Application (2018-2023)
Table 46. Global Cancer Nanomedicine Revenue Share by Application (2024-2029)
Table 47. Cancer Nanomedicine Price by Application (2018-2023) & (US$/Unit)
Table 48. Global Cancer Nanomedicine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Cancer Nanomedicine Sales by Type (2018-2023) & (K Units)
Table 50. US & Canada Cancer Nanomedicine Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Cancer Nanomedicine Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Cancer Nanomedicine Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Cancer Nanomedicine Sales by Application (2018-2023) & (K Units)
Table 54. US & Canada Cancer Nanomedicine Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Cancer Nanomedicine Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Cancer Nanomedicine Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Cancer Nanomedicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Cancer Nanomedicine Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Cancer Nanomedicine Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Cancer Nanomedicine Sales by Country (2018-2023) & (K Units)
Table 61. US & Canada Cancer Nanomedicine Sales by Country (2024-2029) & (K Units)
Table 62. Europe Cancer Nanomedicine Sales by Type (2018-2023) & (K Units)
Table 63. Europe Cancer Nanomedicine Sales by Type (2024-2029) & (K Units)
Table 64. Europe Cancer Nanomedicine Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Cancer Nanomedicine Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Cancer Nanomedicine Sales by Application (2018-2023) & (K Units)
Table 67. Europe Cancer Nanomedicine Sales by Application (2024-2029) & (K Units)
Table 68. Europe Cancer Nanomedicine Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Cancer Nanomedicine Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Cancer Nanomedicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Cancer Nanomedicine Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Cancer Nanomedicine Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Cancer Nanomedicine Sales by Country (2018-2023) & (K Units)
Table 74. Europe Cancer Nanomedicine Sales by Country (2024-2029) & (K Units)
Table 75. China Cancer Nanomedicine Sales by Type (2018-2023) & (K Units)
Table 76. China Cancer Nanomedicine Sales by Type (2024-2029) & (K Units)
Table 77. China Cancer Nanomedicine Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Cancer Nanomedicine Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Cancer Nanomedicine Sales by Application (2018-2023) & (K Units)
Table 80. China Cancer Nanomedicine Sales by Application (2024-2029) & (K Units)
Table 81. China Cancer Nanomedicine Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Cancer Nanomedicine Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Cancer Nanomedicine Sales by Type (2018-2023) & (K Units)
Table 84. Asia Cancer Nanomedicine Sales by Type (2024-2029) & (K Units)
Table 85. Asia Cancer Nanomedicine Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Cancer Nanomedicine Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Cancer Nanomedicine Sales by Application (2018-2023) & (K Units)
Table 88. Asia Cancer Nanomedicine Sales by Application (2024-2029) & (K Units)
Table 89. Asia Cancer Nanomedicine Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Cancer Nanomedicine Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Cancer Nanomedicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Cancer Nanomedicine Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Cancer Nanomedicine Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Cancer Nanomedicine Sales by Region (2018-2023) & (K Units)
Table 95. Asia Cancer Nanomedicine Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Cancer Nanomedicine Sales by Type (2018-2023) & (K Units)
Table 97. Middle East, Africa and Latin America Cancer Nanomedicine Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Cancer Nanomedicine Sales by Application (2018-2023) & (K Units)
Table 101. Middle East, Africa and Latin America Cancer Nanomedicine Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Cancer Nanomedicine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Cancer Nanomedicine Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Cancer Nanomedicine Sales by Country (2018-2023) & (K Units)
Table 108. Middle East, Africa and Latin America Cancer Nanomedicine Sales by Country (2024-2029) & (K Units)
Table 109. Alnylam Pharmaceuticals, Inc Company Information
Table 110. Alnylam Pharmaceuticals, Inc Description and Major Businesses
Table 111. Alnylam Pharmaceuticals, Inc Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Alnylam Pharmaceuticals, Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Alnylam Pharmaceuticals, Inc Recent Developments
Table 114. Amgen Inc Company Information
Table 115. Amgen Inc Description and Major Businesses
Table 116. Amgen Inc Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Amgen Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Amgen Inc Recent Developments
Table 119. Arrowhead Pharmaceuticals, Inc Company Information
Table 120. Arrowhead Pharmaceuticals, Inc Description and Major Businesses
Table 121. Arrowhead Pharmaceuticals, Inc Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Arrowhead Pharmaceuticals, Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Arrowhead Pharmaceuticals, Inc Recent Developments
Table 124. AstraZeneca Company Information
Table 125. AstraZeneca Description and Major Businesses
Table 126. AstraZeneca Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. AstraZeneca Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. AstraZeneca Recent Developments
Table 129. Cadila Pharmaceuticals Company Information
Table 130. Cadila Pharmaceuticals Description and Major Businesses
Table 131. Cadila Pharmaceuticals Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Cadila Pharmaceuticals Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Cadila Pharmaceuticals Recent Developments
Table 134. CELGENE CORPORATION Company Information
Table 135. CELGENE CORPORATION Description and Major Businesses
Table 136. CELGENE CORPORATION Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. CELGENE CORPORATION Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. CELGENE CORPORATION Recent Developments
Table 139. Celsion Corporation Company Information
Table 140. Celsion Corporation Description and Major Businesses
Table 141. Celsion Corporation Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. Celsion Corporation Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Celsion Corporation Recent Developments
Table 144. Genzyme Company Information
Table 145. Genzyme Description and Major Businesses
Table 146. Genzyme Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Genzyme Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Genzyme Recent Developments
Table 149. Merck & Co., Inc Company Information
Table 150. Merck & Co., Inc Description and Major Businesses
Table 151. Merck & Co., Inc Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. Merck & Co., Inc Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Merck & Co., Inc Recent Developments
Table 154. Nippon Kayaku Co.,Ltd Company Information
Table 155. Nippon Kayaku Co.,Ltd Description and Major Businesses
Table 156. Nippon Kayaku Co.,Ltd Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Nippon Kayaku Co.,Ltd Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Nippon Kayaku Co.,Ltd Recent Developments
Table 159. Nanobiotix Company Information
Table 160. Nanobiotix Description and Major Businesses
Table 161. Nanobiotix Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Nanobiotix Cancer Nanomedicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Nanobiotix Recent Developments
Table 164. Pfizer Inc Company Information
Table 165. Pfizer Inc Description and Major Businesses
Table 166. Pfizer Inc Cancer Nanomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Pfizer Inc Cancer Nanomedicine Product Model

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nanopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 153

According to our LPI (LP Information) latest study, the global Nanopharmaceuticals market size was valued at US$ 30290 million in 2023. With growing demand in downstream market, the Nanopharmaceuticals is forecast to a readjusted size of US$ 73420 million by 2030 with a CAGR of 13.5% during review period. The research report highlights the growth potential of the global Nanopharmaceuticals market. Nanopharmaceuticals are expected to show stable growth in the future market. However, produ......

Global Nanomedicine Market Research Report 2023

Published: 14-Dec-2023        Price: US 2900 Onwards        Pages: 87

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nanomedicine market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Combimatrix - Ablynx - Abraxis Bioscience - Celgene - Mallinckrodt - Arrowhead Research - GE Healthcare - Merck - Pfizer - Na......

Global Nanomedicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 30-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Nanomedicine market: According to our latest research, the global Nanomedicine market looks promising in the next 5 years. As of 2022, the global Nanomedicine market was estimated at USD 181.26 million, and it's anticipated to reach USD 263.67 million in 2028, with a CAGR of 6.45% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nanomedicine market, with......

Nanomaterials in Personalized Medicine: Global Markets

Published: 20-Oct-2023        Price: US 5500 Onwards        Pages: 226

Report Scope: The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competiti......

2023-2031 Report on Global Nanopharmaceuticals Market by Player, Region, Type, Application and Sales Channel

Published: 09-Oct-2023        Price: US 2500 Onwards        Pages: 122

This report studies the Nanopharmaceuticals market, covering market size for segment by type (Liposomes, Polymeric Micelles, etc.), by application (Cancer and Tumor, Autoimmune Disorders, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck, Pfizer, Novartis, Abbott, GlaxoSmithKline, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Na......

Global Cancer Nanomedicine Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 111

Nanomedicine is a branch of nanotechnology that uses nanoparticles to diagnose, treat, monitor, and control biological systems. By manipulating materials at the nanoscale, it improves medicine delivery. As a result, nanomedicine has helped treat a wide range of diseases. Nanomedicine is still in its infancy, with numerous products in the works. Nanobiotix has identified 230 nanomedicine products that are either patented or in the early stages of development. 49 of the 230 products are on the mar......

Asia-Pacific Nanotechnology In Energy Applications Market Forecast 2023-2032

Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 175

KEY FINDINGS The Asia-Pacific nanotechnology in energy applications market is projected to grow with a CAGR of 13.24% during the forecasting years of 2023-2032. The regional market's growth is ascribed to the gradual improvement of the nanotechnology profile in scientific research, supportive government policies and regulations aimed at promoting renewable energy as well as reducing carbon footprint, and rising concerns associated with greenhouse emissions and safety. ......

Europe Nanotechnology In Energy Applications Market Forecast 2023-2032

Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 165

KEY FINDINGS The Europe nanotechnology in energy applications market is set to grow with a CAGR of 12.89% over the forecast period of 2023-2032. The regional market's growth is accredited to the European Union's (EU) significant role in promoting nanotechnology in the energy sector as well as the efforts directed toward the transition to a low-carbon economy and minimizing greenhouse gas emissions. MARKET INSIGHTS The United Kingdom, Italy, Spain, Pol......

North America Nanotechnology In Energy Applications Market Forecast 2023-2032

Published: 18-Aug-2023        Price: US 1600 Onwards        Pages: 168

KEY FINDINGS The North America nanotechnology in energy applications market is estimated to record a CAGR of 13.01% over the forecast period of 2023-2032. The market growth of the region is augmented by increasing customer demand for high-performance, longer-lasting products, the introduction of new standards and technologies, as well as evolving regulatory requirements. MARKET INSIGHTS Canada and the United States are evaluated for the North America ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs